IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Sweden

  • ID: 1408497
  • Report
  • Region: Sweden
  • 43 Pages
  • IMS Health
1 of 3
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets. This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.
Note: Product cover images may vary from those shown
2 of 3
1. Healthcare System
Facts & Figures
Market Indicators
Provision & Funding

2. Pricing
Prescription Drugs
Overview
TLV
County Councils
Pharmacy Discounts
7.5% Price Cuts for Older Drugs
Generic Drugs
Ceiling Prices
7.5% Price Cuts for Older Drugs
Hospital Drugs
TLV
County Councils
OTC Drugs

3. Reimbursement
Admission to Reimbursement
TLV
County Councils
Reimbursement Categories
Reimbursement Prices
Hospital Reimbursement
Health Economic Assessments of Hospital Drugs
Formularies
Funding
Changes in Reimbursement Status
Reassessment Process
Recent Reassessments
Abandoned Reassessments
Ongoing Reassessments
Products with Restricted or Conditional Reimbursement Approval
Changes in Reimbursement Prices
Patented Drugs
Off-patent Drugs
New Dosage Forms, Pack Sizes and Strengths

4. Pharmacoeconomics
Pharmacoeconomic Requirements
Guidelines
Evaluation
Hospital Drugs

5. Price Build Up
Wholesalers
Margins
Background
Retail Pharmacies
Margins
Review of Pharmacy Margins
Background
Pharmacy Market Review
E-pharmacy
Multi-dose Dispensing
Dispensing Doctors
Sales Tax

6. Cost Containment
Industry Paybacks
Promotional Costs
Patient Co-payments
Pharmaceuticals
Healthcare
Prescribing Controls
Funding Agreement
Prescribing Budgets
Drug Committees
NT Council
National Guidelines
E-prescriptions
Generics
Generic Substitution
INN Prescribing
Rx-to-OTC Switches
Switching Process
Liberalised OTC Sales
OTC Market
Parallel Trade
Parallel Import Market
Pricing Regulations
Price Discounts
Parallel Import Substitution

7. Future Developments
Outlook
Review of Drug Financing, Pricing and Reimbursement
Review of the Processes for Introducing New Drugs
Other Developments

8. Names & Addresses
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll